Status:
COMPLETED
Serum iPTH, Calcium and Phosphate, and the Risk of Mortality in Beijing Elderly Hemodialysis Population
Lead Sponsor:
Wenhu Liu
Conditions:
End Stage Renal Disease
Eligibility:
All Genders
65+ years
Brief Summary
Incidence of End Stage Renal Disease (ESRD) amongst elderly patient group is continuously increasing with population aging progressing. Mineral and bone disorder (MBD) is a common complication caused ...
Eligibility Criteria
Inclusion
- The data shall include the information of elderly hemodialysis patients who were 65 years or elder between Jan 1st, 2012 and Dec 31st, 2016
Exclusion
- The patients who only has less than 6 months history of hemodialysis since selected in the research patient group The patients who passed away within 3 months since selected in the research patient group The patients who took less than 3 hemodialysis in a week The patients who took kidney transplant during the research time period The patients who do not have blood biochemical results in the records
Key Trial Info
Start Date :
January 1 2012
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
December 31 2016
Estimated Enrollment :
1000 Patients enrolled
Trial Details
Trial ID
NCT03261154
Start Date
January 1 2012
End Date
December 31 2016
Last Update
August 24 2017
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Beijing Friendship hospital
Beijing, Beijing Municipality, China, 100050